MAPT and Alzheimer disease: These investigators found in this relatively large sample of AD and FTLD cases including tauopathies and TDP-43opathies that CSF Aβ42/Aβ40 or p-tau/Aβ42 ratios diagnose not only primary AD but also AD co-pathology in PSP and FTLD-tau.